Congress file hr8005-119, before Congress. Still to be decided as of 2026-09-15.
Latest action: The title of the measure was amended. Agreed to without objection.
Sellers of fake fentanyl face harsher prison time People who make, sell, or help distribute counterfeit fentanyl or methamphetamine pills now face the same stiff criminal penalties as large-scale drug manufacturers, with sentences handed down by federal courts.
DEA launches coordinated crackdown on pill manufacturing The Drug Enforcement Administration must create a 180-day plan to seize fake pills, boost youth education programs like Operation Engage, and audit existing awareness campaigns like One Pill Can Kill to see what works.
Bill targets pills but may miss powder and liquid forms The law focuses on counterfeit fentanyl and methamphetamine substances that are sold as pills under a fake brand name; traffickers who sell the same drugs in powder or liquid form face no new penalties under this bill.
This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances. Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine). The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.
Read the official record for hr8005-119
See everything up for a vote · This week in Congress · See what we have filed with the clerk